"The technology is based on the "T-cell receptor", the protein that sticks out of the surface of the T-cell and binds to its enemy target. Immunocore's ImmTACs are effectively independent T-cell receptors that are "bispecific", meaning they bind strongly to cancer cells at one end, and T-cells at the other – so introducing cancer cells to their nemesis."
E3 2013: Dragon Age Inquisition and the Next Generation - IGN
Is Dragon Age Inquisition more like the last one or Origins? BioWare explains a bit about its next-gen RPG philosophy.
Newegg nukes “corporate troll” Alcatel in third patent appeal win this year
Company takes hard line on patent cases, and keeps winning.
Google Has Been Working on Watch and Glass in Tandem, Patents Show
If Google Glass freaks too many people out, the company likely has a Plan B close behind.
Glassdoor – an inside look at jobs & companies
Search jobs then look inside. Company salaries, reviews, interview questions, and more - all posted anonymously by employees and job seekers
Gamasutra - News - Mythic Co-Founder Mark Jacobs Reveals New Social, Cas...
Mark Jacobs, formerly CEO at Warhammer Online developer Mythic Entertainment, has founded a new studio called City State Entertainment that
Nimble social CRM Platform | Social Relationships Made Easy
Nimble is the only solution to offer small businesses the best features of high-end CRM systems combined with the power of social media.
Help This Girl Win Justin Bieber's 'Girlfriend Sing-Off' Contest or You'...
The short of it is that Justin Bieber is promoting his new fragrance "Girlfriend" by asking all his lady fans (of which, I'm told, there is